Abstract
The hormone Neuropeptide Y (NPY) plays critical roles in feeding, satiety, obesity, and weight control. However, its complex peptide structure has hindered the development of fast and biocompatible detection methods. Previous studies utilizing electrochemical techniques with carbon fiber microelectrodes (CFMEs) have targeted the oxidation of amino acid residues like tyrosine to measure peptides. Here, we employ the modified sawhorse waveform (MSW) to enable voltammetric identification of NPY through tyrosine oxidation. Use of MSW improves NPY detection sensitivity and selectivity by reducing interference from catecholamines like dopamine, serotonin, and others compared to the traditional triangle waveform. The technique utilizes a holding potential of −0.2 V and a switching potential of 1.2 V that effectively etches and renews the CFME surface to simultaneously detect NPY and other monoamines with a sensitivity of 5.8 ± 0.94 nA/µM (n = 5). Furthermore, we observed adsorption-controlled, subsecond NPY measurements with CFMEs and MSW. The effective identification of exogenously applied NPY in biological fluids demonstrates the feasibility of this methodology for in vivo and ex vivo studies. These results highlight the potential of MSW voltammetry to enable fast, biocompatible NPY quantification to further elucidate its physiological roles.
Graphical Abstract
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Numerous human diseases and disorders can be attributed to an inherent perturbation in the equilibrium of biomolecules and neurotransmitters (NT). However, distinguishing and detecting these molecules remains a challenging task [1]. Neuropeptides, which are composed of multiple amino acid residues, are an alternative class of neurohormones that play a crucial role in the transmission and modulation of neurological impulses. It is essential to achieve high temporal and spatial resolution for the accurate and biocompatible measurement of neuropeptides [1]. Neuropeptides are commonly released with other neurotransmitters, thereby presenting a significant obstacle in their selective and sensitive measurement [2, 3]. NPY is composed of 36 amino acids and is one of the foremost significant human neurotransmitters [2]. It plays a role in the regulation of physiological processes, including the manifestation of depressive symptoms [4], hunger/satiety, feeding [5], memory [6], fear [7], and stress [4, 8].
Several methods have been used to measure and quantify NPY. Previous studies have employed mass spectrometry in combination with chromatographic separation to quantify NPY. Studies have utilized high-performance liquid chromatography-mass spectrometry (HPLC-MS) for the analysis of NPY in plasma samples [9]. However, these methodologies have exhibited certain constraints in terms of their sensitivity, hence posing a challenge in acquiring diagnostic data, particularly when dealing with small sample volumes [3]. Another work has reported a limit of detection of 1 nM for NPY in plasma samples, with an analysis time of approximately 25 min per sample, and this method focused solely on quantifying NPY [10]. Other studies have utilized mass spectrometric detection, which enabled high sensitivity and selectivity, but often had relatively lower spatiotemporal resolution than other methods [11]. Immunoassays exhibit a notable capacity to attain high levels of sensitivity, as evidenced by their ability to detect concentrations as low as picomolar levels. NPY has also been isolated from brain and sweat samples via microdialysis [3]. However, this required off-line analysis of the collected dialysate, involving either HPLC with electrochemical detection or immunoassays [3]. Moreover, Vocat et al. reported detecting NPY levels as low as 0.25 pM in sweat patch samples. These immunoassays measured total immunoreactive NPY for the full immunoassay, which includes NPY metabolites and fragments that cross-react with the antibody [13].
The use of electrochemical detection techniques has garnered considerable attention as a prompt and effective approach for quantifying biomolecules. The utility of capillary electrophoresis with electrochemical detection (CE-EC) allows for rapid assessment of neurochemicals. Analyzing NPY is challenging due to sensitivity issues, as reported by Crespi et al. [12]. However, the tyrosine residues within NPY peptides have higher oxidation potentials (~1.0 V) than do commonly measured compounds such as catecholamines (~0.6 V), potentially enabling their co-detection alongside monoamines through the discrimination of their oxidation peaks [15]. Thus, establishing precise techniques for these less common, yet biologically significant, peptides is essential and very useful. The electrochemical detection of neuropeptides containing tyrosine, such as enkephalins (ENKs), has added challenges that has recently been addressed. It is hypothesized that these molecules are found at relatively low concentrations in the extracellular space for short durations, and they adsorb to the electrode surface where oxidation occurs. Several electrochemical methods such as the modified sawhorse waveform have been used to measure oxytocin in animal models such as zebrafish using fast-scan cyclic voltammetry (FSCV) [13, 14]. Endogenous peptides such as met-enkephalin and leu-enkephalin have previously been measured electrochemically through the oxidation of tyrosine residues [15,16,17]. While the MSW has been extensively characterized for smaller molecules and neuropeptides, its application to the detection of larger neuropeptides, such as Neuropeptide Y (NPY), represents a novel endeavor. NPY has been measured with several electrochemical techniques such as square wave voltammetry and electrochemical impedance spectroscopy (EIS) [1, 18]. Moreover, electrodes have been modified with aptamers [19], polypyrrole [20], and methylene blue dye to enhance the sensitivity and selectivity of the measurement of NPY with the aforementioned techniques [1, 18]. Therefore, the measurement of the tyrosine-containing NPY with electrochemical techniques seems promising for the sensitive and selective measurement of this peptide.
Here, we develop an assay for the electrochemical measurement of NPY with CFMEs and FSCV. We utilized MSW for the direct and minimally invasive detection of NPY, achieving high spatiotemporal resolution. The MSW waveform encompasses two separate scan rates during each anodic sweep, while also introducing a short period of holding at the switching potential (1.2 V). We address two key challenges: minimizing electrode fouling difficulties and boosting the chemical resolution in the detection of peptides that contain tyrosine. Through this work, we have expanded the range of possible applications for carbon fiber microelectrodes to measure several tyrosine-containing peptides with FSCV. As a result, these electrodes can now be utilized for the detection of not just small compounds but also larger and more intricate molecules, such as neuropeptides, including NPY [21]. MSW was used to measure NPY through targeted oxidation of its tyrosine residue. In this work, we demonstrated that NPY measurement was enhanced utilizing the MSW waveform as opposed to the traditional waveform. We also showed that NPY was adsorption-controlled to the surface of CFMEs and had stable detection for several hours in addition to being fouling resistant. We co-detected NPY in complex solutions with other monoamines and catecholamines such as dopamine, serotonin, norepinephrine, and others. Moreover, NPY was also measured in complex biological fluids illustrating proof-of-concept potential measurement in animal models. As opposed to conventional techniques, we have developed a fast, sensitive, selective, biocompatible, and minimally invasive assay with high spatiotemporal resolution to measure NPY. This will potentially enhance the measurement of NPY and further understanding of its physiological role in vivo.
Materials and methods
Chemicals
The experimental components utilized in the study were comprised of high-purity reagents. Tyrosine and dopamine, both with a purity level surpassing 98.0%, were obtained from Sigma-Aldrich (St. Louis, MO). NPY was obtained from GenScript Biotech (Piscataway, NJ). The electrochemical studies were performed using a phosphate-buffered saline (PBS) solution, which consisted of specific concentrations of several components. These components included 131.5 mM NaCl, 3.25 mM KCl, 1.2 mM CaCl2, 12.5 mM NaH2PO4, 1.2 mM MgC12, and 2.0 mM Na2SO4. The pH of the solution was adjusted to 7.4.
CFME fabrication
The fabrication process of carbon fiber microelectrodes (CFMEs) occurred by using T-650 carbon fibers (Goodfellow, UK), which are derived from polyacrylonitrile (PAN). A T-650 carbon fiber strand with a diameter of approximately 7 μm was carefully aspirated into a glass capillary (A-M Systems, Sequim, WA) with an inner diameter of 0.68 mm and an exterior diameter of 1.2 mm. A vacuum pump (Gast, Model DOA-P704-AA, Benton Harbor, MI) was utilized to aspirate the fiber into a glass capillary. Following that, the glass was tapered using a micropipette vertical capillary puller (Narishige, PC-100, Tokyo, Japan). The carbon fiber’s protruding end was cut to a length of approximately 100 to 150 μm from the tapered side of the glass capillary. The glass-carbon fiber interface was sealed with EPON 828 epoxy resin and diethylenetriamine (DETA) hardener. The epoxy was cured for 4 h at a temperature of 125 °C. A 4 M KCl solution was used to backfill the electrodes to create an electrical connection with the electrode holder.
Fast-scan cyclic voltammetry (FSCV)
A WaveNeuro fast-scan cyclic voltammetry (FSCV) potentiostat was equipped with a 5 MΩ headstage and supplied by Pine Instruments (Durham, NC). High-definition cyclic voltammetry (HDCV) software, in conjunction with the PC1e-6363 multifunction I/O device produced by NI (Austin, TX), was used to collect and analyze the data. A conventional triangle waveform was utilized, where the holding potential was set at −0.4 V and the switching potential was set at 1.3 V. A scan rate of 400 V/s was employed, with a silver-silver chloride reference electrode (Ag/AgCl) maintained at a potential of 0.197 V and a frequency of 10 Hz. The MSW was also introduced at a frequency of 10 Hz. The initial resting potential of the waveform was set at −0.2 V and subsequently increased to +0.7 V at a rate of 100 V/s. It proceeded to increase to a value of +1.2 V while being subjected to a higher scan rate of 400 V/s. The potential was sustained for a brief period of 3 ms, followed by a rapid decrease to −0.2 V, with a scan rate of 100 V/s.
To maintain a consistent and uninterrupted flow of solution, the buffer solution was administered to the electrode tip at a steady rate of 1 mL/min, facilitated by the NE-300 Just Infusion Syringe Pump (New Era Systems, Farmingdale, NY) and a FSCV flow injection analysis flow cell (Pine Research, Durham, NC). In each experimental iteration, 0.2-mL aliquots of NPY were injected into the system. The electrode was allowed to equilibrate with the waveform applied for a minimum duration of 30 min, which was allotted for each electrode prior to conducting in vitro measurements within the flow cell.
Statistical analysis
GraphPad Prism 9 was utilized for the preparation of figures and execution of linear regression computations, encompassing the calculation of slope and R2 values. This was important for obtaining the statistical significance between the urine samples and the buffer. Several data sets were normalized by dividing all of the peak oxidative currents by the largest current in the data set to normalize to “1” or “100%.” The normalized current was obtained by dividing each peak oxidative current by the highest current to account for differences in protruding length of the carbon fiber from electrode to electrode.
Results and discussion
Neuropeptide Y measurement
NPY is an endogenous peptide consisting of 36 amino acids arranged linearly, with tyrosine groups located at both ends of the molecule [22]. The tyrosine residues within the NPY structure serve as crucial redox moieties with significant functional importance. The electrochemical oxidation-reduction of tyrosine is characterized by a proton-coupled electron transfer (PCET) mechanism. The PCET process arises due to the distinct acid dissociation constants observed for tyrosine in its oxidized state (pKOX < 0) and reduced state (pKRED ∼ 10). This phenomenon is significant within the context of the limited pH range in which proteins can maintain their structural stability and catalytic activity [15, 23]. Tyrosine is oxidized into a free radical intermediate through a concerted mechanism (Fig. 1).
MSW measurements of NPY
We employed the MSW with various voltages, scan rates, and hold times. The MSW waveform was designed to maintain a holding potential of −0.2 V during the scan. The scan was initiated at a rate of 100 V/s and continued until it reached a transition potential of 0.7 V. After reaching 0.7 V, there is a transition in the scan rate, which increases to 400 V/s. This elevated scan rate is maintained until reaching the switching potential of 1.2 V where it is held constant for a specific duration of 3 ms. Subsequently, the scanning process continues and scans down until reaching a voltage of −0.2 V, with a constant rate of 100 V/s. As shown in previous studies [13], holding the potential at 1.2 V for 3 ms improved adsorption and promoted effective electron transfer kinetics on the surface of carbon fiber microelectrodes (CFMEs). Maintaining a potential of 1.2 V facilitates the oxidation of tyrosine and enhances the flow of electrons between the analyte and the surface of the CFME. At this potential, the waveform can etch the electrode and renew the surface, which enhances sensitivity and prevents biofouling [13, 17]. This is supported by the distinct shape of the cyclic voltammogram (CV) peak. Several studies have shown NPY to be present and physiologically active at nanomolar and micromolar levels, which makes this assay relevant for the measurement of NPY [24,25,26,27].
We observe an oxidation peak at about 1.0 V and a secondary peak at about 0.4 V, which could be the result of an acid shift due to several acidic amino acid moieties included in NPY. This secondary peak could be utilized to distinguish NPY from the electrochemical detection of other tyrosine-containing peptides such as oxytocin [13], leu-enkephalin [17], and met-enkephalin [16]. The triangle waveform was not able to detect and measure NPY, and produced higher noise and lower peak oxidative currents at a concentration of 20 μM (Fig. 2A). We observe higher peak oxidative currents at around 1.1 V for an electrode measuring NPY at the same concentration of 20 μM when applied with the MSW waveform (Fig. 2B). Therefore, we have shown that applying the CFME with MSW, as opposed to the conventional triangle waveform, has significantly enhanced NPY measurements with FSCV (Fig. 2B). When compared across multiple electrodes, CFMEs applied with the MSW yield significantly higher peak oxidative currents and better peak shape for tyrosine detection than those applied with the traditional triangle waveform (Fig. 2C, n = 6, p < 0.0001). The background charging capacitive currents of electrodes applied with the MSW and triangle waveforms were of comparable magnitude (Fig. 2D). Therefore, we expect that the electrodes had comparable surface roughness and area when applied with the two waveforms. Any differences in peak oxidative current and CV shape was hypothesized to arise from faradaic current arising from direct electrron transfer at the surface of the electrode and not from any changes in the background charging current, which are similar in magnitude.
The selectivity of an analytical technique is a crucial factor that determines its applicability and reliability, particularly in complex biological matrices. The detection of NPY relies on the oxidation of its tyrosine residues, which are also present in various other peptides and electroactive biomolecules. These peptides could potentially contribute to the electrochemical signal, leading to inaccurate measurements of NPY. However, the presence of other redox active amino acid residues within the peptide, such as tyrosine, phenylalanine, tryptophan, cysteine, and potentially others, offers the possibility of selectively measuring peptides with this technique. The unique properties of NPY that enhance its selectivity and distinguish it from other peptides are primarily related to its size and the presence of multiple tyrosine residues. Research has demonstrated that the larger size of NPY contributes to its adsorption-controlled oxidation kinetics [16]. NPY contains five tyrosine residues, which are electroactive and contribute to the oxidation signal. The presence of multiple tyrosine residues in NPY can result in a unique electrochemical signature compared to peptides with fewer or no tyrosine residues [28]. As opposed to oxytocin, NPY has a secondary oxidation peak at approximately ~0.4 V and a primary oxidation peak at ~1.0 V; therefore, we are able to differentiate NPY from other tyrosine-containing peptides.
Concentration experiments
We then attempted to vary the concentration to measure adsorption control dynamics at the surface of NPY at the surface of CFMEs. In typical cyclic voltammograms (CVs) of NPY oxidation utilizing the MSW waveform at different concentrations with current increasing with concentration, we observed an increasing peak oxidative current of the CVs upon increasing the concentration of NPY from 5 to 15 µM (Fig. 3A). An increasing peak oxidative current of the CVs upon increasing the concentration was observed (Fig. 3B). Moreover, a linear response is observed between 5 and 15 µM (Fig. 3C) (R2 = 0.914). This illustrates that peak oxidative current is linear with respect to concentration up to 15 µM as denoted by the Randles-Sevcik equation for voltammetric analysis. At concentrations higher than 15 µM (Fig. 3D), the plot deviates from linearity forming a discernible asymptotic curve. As such, we hypothesize that NPY adsorption sites become saturated and NPY becomes more diffusion-controlled at the electrode surface, which can explain the deviation from linearity and asymptotic curve at higher concentrations. At higher concentrations, NPY and other molecules become saturated at the surface of the electrode and, hence, fill up adsorption sites at the electrode surface, which promote more diffusion control at higher concentrations [28].
Scan rate and stability experiments
We then varied the scan rate (upward scan) of the first upward scan from 100 to 400 V/s in 100 V/s increments. Upon plotting peak oxidative current vs. scan rate (Fig. 4A), we observed a linear relationship between peak oxidative current and scan rate (R2 = 0.729). Therefore, we hypothesize that the kinetics of NPY are adsorption-controlled at the electrode surface. Adsorption-controlled processes allowed for increased sensitivity in comparison to diffusion-controlled kinetics where peak oxidative current would be proportional to the square root of scan rate. When the molecule adsorbs to the microelectrode surface, it enhances electron transfer and sensitivity, which can produce lower limits of detection [29, 30]. Moreover, we also observed strong linear correlation between peak oxidative current and the square root of scan rate (R² = 0.83) (Fig. 4B). Therefore, we hypothesize that there is partial adsorption and diffusion control of NPY at the surface of the electrode.
Using the MSW, we observed a stable peak oxidative current response over 4 h, while successfully detecting a concentration of 5 μM of NPY (Fig. 4C). Here, the electrode was continuously applied with the MSW and was stable over 4 h. It is worth noting that the 4-h duration corresponds to the standard timeframe typically employed for conducting in vivo measurement. Applying the MSW etches and renews the surface of the carbon fiber, which could potentially increase background capacitance and drift [31, 32]. Therefore, the electrode is allowed to equilibrate for approximately 30 min to prevent any additional electrode drift throughout the duration of the experiment. The mechanism of adsorption is postulated to be an electrostatic attraction of opposite charges where positively charged amino acid residues of NPY are electrostatically attracted to and adsorb on the negatively charged electrode surface. Moreover, the phenyl group of tyrosine could also undergo π-π stacking with the surface of the graphitic carbon fiber microelectrode as well [33]. Maintaining a stable response over 4 h is important as it is the typical duration of ex vivo and in vivo studies [34]. The application of the MSW enables the detection of NPY, even at lower concentrations, and establishes the capability for the possible detection of endogenous NPY in living organisms at physiological levels. Moreover, the stability experiment (Fig. 4C) provides additional evidence supporting the consistent accuracy of NPY detection when utilizing the MSW. These findings demonstrate that there were no significant variations observed over a 4-h duration.
Fouling experiments
Fouling occurs when an analyte polymerizes and forms non-conductive coatings on the electrode surface, preventing sites for subsequent adsorption and, hence, lowers the sensitivity of electrochemical detection [35,36,37,38]. Molecules such as serotonin and one of its major downstream metabolites, 5-hydroxyindoleacetic acid (5-HIAA), produce extremely reactive radicals during the oxidation process. These radicals then polymerize to form non-conductive coatings on the surface of the carbon fiber microelectrode (CFME), which can diminish analyte detection [39]. These coatings obstruct electron transfer, causing electrode fouling and reducing peak oxidative current.
We attempted to determine whether other molecules such as NPY also foul the electrode surface. Following ten consecutive injections of 20 μM NPY onto the CFME in the flow cell (Fig. 5) shows that when using the MSW, there is no detectable decrease in peak oxidative current over repeated ten repeated injections of NPY (approximately 5 min). The application of the MSW effectively reduces fouling at the electrode surface. It is hypothesized that holding the upper potential limit at 1.2 V for 3 ms prevents biofouling by etching the electrode and renewing the electrode surface, which prevents the coating of the electrode surface in non-conductive polymer films. Previous studies have revealed that applying this waveform may etch and renew the microelectrode surface [32, 40,41,42,43], which would make it an appropriate waveform for NPY detection and the prevention of fouling at the electrode surface as well.
Prior research has shown that scanning to higher potentials than 1.2 V favors the renewal of the electrode surface through etching [13]. This etching process breaks carbon-carbon bonds, increases the surface roughness, which causes the electroactive surface area and aspect (surface to volume) ratio to grow, and functionalizes the electrode surface with negatively charged oxide groups such as oxides, hydroxy, carbonyl, carboxyl, ketones, and others, which can adsorb positively charged cations such as monoamines [32]. Analyte fouling at the electrode surface is efficiently prevented by regenerating the electrode surface through electrochemical etching. This continuous renewal of the electrode surface prevents non-conductive polymers from coating the electrode surface, ensuring that the electrode stays functional and prevents coating with non-conductive polymer throughout the duration of the experiment [44].
We also performed a fouling experiment where we applied the electrode with the MSW in vitro. In the flow cell, we injected 20 μM of NPY every 30 s for a total of ten injections for a total run time of 300 s (5 min). We observed no statistically significant difference in peak oxidative current vs. injection number when plotting the normalized peak oxidative current vs. injection number or time (Fig. 5) (p = 0.33). Therefore, we hypothesize that NPY does not foul the surface of the electrode when applied with the MSW.
Co-detection experiments
We then employed the MSW to investigate the electrochemical responses of dopamine (DA) and NPY in complex mixtures throughout a concentration range of 1 μM DA to 20 μM of NPY. The results consistently showed unique and defined oxidation potentials, with NPY oxidizing at approximately +1.1 V and dopamine oxidizing at +0.5 V. As we increased the concentration of NPY, the peak oxidative current of the NPY CV increased, while that of dopamine remained relatively constant, which further illustrated the co-detection of both DA and NPY as they oxidized at substantially different potentials (Fig. 6). Therefore, it was possible to co-detect and differentiate both molecules from one another in a complex mixture.
When the concentrations of DA and NPY were equal, we were not able to observe the CV current peak for NPY due to a relatively higher sensitivity for DA at the electrode surface. Peak oxidative currents for NPY increased significantly when NPY was present at higher concentrations relative to DA (at a 1:20 ratio). When NPY concentrations were at the lower end, noise levels rose as the concentration levels approached the limit of detection. This phenomenon can mostly be attributed to the relatively facile nature of dopamine oxidation at CFMEs, which is more amenable to electron transfer at the electrode surface due to its smaller size and faster electron transfer kinetics where the catechol moiety is oxidized to a quinone and then reduced back to a catechol. Furthermore, when co-detecting dopamine with NPY or tyrosine, our experiments revealed a notable separation of oxidation peaks. The variable rates of heterogeneous electron transfer of dopamine and NPY when interacting with carbon fiber microelectrodes (CFMEs) could explain this phenomenon. One potential explanation for the separation of the dopamine and NPY peaks is the use of multiple scan rates during the MSW application. Within the theoretical window, favorable to dopamine oxidation, the scan rate is maintained at 100 V/s, while it increases to 400 V/s for NPY. Because dopamine has a faster electron transfer rate, its oxidation peak exhibits more significant alterations in response to changes in scan rate. As the scan rate is reduced, the dopamine oxidation peak shifts to more negative potentials. In contrast, when the scan rate is constant throughout, the peak oxidative position for tyrosine or NPY remains rather stable. This work is important as the carbon fiber microelectrode sensors could potentially be used to measure NPY in complex heterogeneous environments in the brain that also contain other biologically relevant molecules such as monoamine neurotransmitters. Therefore, it is important to be able to co-detect and differentiate NPY from other monoamine neurotransmitters such as dopamine.
Co-detection of NPY with other monoamine neurotransmitters
In addition to the dopamine co-detection experiments, we performed interference studies with a variety of other neurochemicals including 8 μM serotonin (5-HT) and 10 μM NPY (Fig. 7A), 6 μM norepinephrine (NE) and 2 μM NPY (Fig. 7B), 20 μM 3,4-dihydroxyphenylacetic acid (DOPAC) and 4 μM NPY (Fig. 7C), and 20 μM 5-hydroxyindoleacetic acid (5-HIAA) and 4 μM NPY(Fig. 7D). Using MSW, we were able to co-detect NPY in complex mixtures with several other monoamine amine neurotransmitters due to the peak separation of the NPY CV oxidation peak from that of the other monoamine interferents. As with dopamine, the other monoamine neurotransmitters oxidize (and have peak oxidation potentials) at approximately 0.6 V, while the peak oxidative potential is approximately 1.1 V for NPY. DOPAC and 5-HIAA were tested at higher concentrations because they are anionic (negatively charged) and, thus, have lower sensitivity than positively charged cations (dopamine and serotonin) because they are electrostatically repelled from the negatively charged (holding potential) and oxide-rich carbon electrode surface.
In comparison to 5-HIAA and DOPAC, NPY consistently showed the greater oxidation peaks among the other chemicals studied. This observation can be explained by the fact that both DOPAC and 5-HIAA are carboxylic acids and anions at a physiological pH. 5-HIAA has been known to generate extremely reactive radicals during the oxidation process [45] and has been shown to foul the electrode surface [40]. These radicals are most likely responsible for the fouling of 5-HIAA at the electrode surface. The monoamine neurotransmitters display comparable electrochemical CV behavior to dopamine as they are similar in size and structure to dopamine and, hence, have comparable redox properties as well. Higher concentrations (20 μM) of DOPAC and 5-HIAA (the carboxylic acid–functionalized analogues of dopamine and serotonin, respectively) were utilized because they are anionic, negatively charged, and do not adsorb to the surface of the electrode because they are electrostatically repelled from the negatively charged electrode surface and are more diffusion controlled. Therefore, higher concentrations must be tested to compensate for this in order to yield comparable peak currents to NPY. The monoamine cations (dopamine, serotonin, and norepinephrine) are cationic, positively charged, and adsorb to the electrode surface, which are more sensitive and produce higher peak currents. This allows for the measurement of relatively lower concentrations as opposed to other molecules that do not adsorb to the electrode surface.
Measurement in biological fluid
Lastly, we performed a proof-of-concept experiment to detect exogenously applied NPY in a biological urine sample. We performed FSCV testing for NPY diluted in buffer and NPY spiked into a urine sample, both at a concentration of 10 μM. The results showed that NPY could be detected even in the presence of urine (Fig. 8). The cyclic voltammograms (CVs) clearly showed a strong, identifiable peak that matched the characteristics observed with in vitro testing. Comparing the same electrodes, there was no statistically significant decrease in peak oxidative current of the CVs between measurements of NPY in buffer or urine as shown in the example CVs (Fig. 8A) and the data across multiple electrodes (Fig. 8B). Redox active interferents such as uric acid found in urine did not hinder NPY detection by CFMEs in urine as opposed to in buffer. The measurement of NPY in urine is an established assay as it serves as a biomarker for urinary tract disorders and renal disease, which makes this biological fluid a suitable model for the measurement of NPY in real samples [49,50,51]. This illustrates the robustness of our electrochemical assay with CFMEs when immersed in biological fluids such as urine. Measuring NPY levels in urine could potentially have biological relevance, as NPY has been reported to be excreted in urine and proposed as a biomarker for certain conditions like obesity, metabolic disorders, and renal diseases [52, 53].
Conclusions
In summary, we have shown that the MSW applied onto CFMEs with FSCV was utilized to successfully measure NPY via the oxidation of tyrosine. The use of the MSW proved to be a critical assay in enhancing NPY detection sensitivity due to the use of a holding potential of 1.2 V, which permitted a more efficient electron transfer processes and prevented biofouling. Notably, our findings reveal that holding the potential at 1.2 V renewed the electrode surface faster than the conventional triangle waveform and allowed more time for analyte oxidation. This significant electrochemical etching of the surface led to a significant improvement in the sensitivity of NPY detection and allowed for the successful co-detection of NPY with multiple monoamines. Furthermore, applying the MSW onto CFMEs increased NPY selectivity by reducing interference from catecholamines such as dopamine and serotonin, thus allowing for co-detection and the distinct separation of NPY’s oxidation peak from those of the monoamine neurotransmitters. The enhanced detection of NPY in urine with this assay indicates the practical utility of this technique for potential real-time in vivo monitoring or in real biological samples.
References
López L, Hernández N, Reyes Morales J, Cruz J, Flores K, González-Amoretti J, et al. Measurement of neuropeptide Y using aptamer-modified microelectrodes by electrochemical impedance spectroscopy. Anal Chem. 2021;93:973–80. https://doi.org/10.1021/acs.analchem.0c03719.
Denison JD, De Alwis AC, Shah R, McCarty GS, Sombers LA. Untapped potential: real-time measurements of opioid exocytosis at single cells. J Am Chem Soc. 2023. https://doi.org/10.1021/jacs.3c07487.
Sanghavi BJ, Varhue W, Chávez JL, Chou CF, Swami NS. Electrokinetic preconcentration and detection of neuropeptides at patterned graphene-modified electrodes in a nanochannel. Anal Chem. 2014;86:4120–5. https://doi.org/10.1021/ac500155g.
dos Santos VV, Santos DB, Lach G, Rodrigues ALS, Farina M, De Lima TCM, et al. Neuropeptide Y (NPY) prevents depressive-like behavior, Spatial memory deficits and oxidative stress following amyloid-β (Aβ1-40) administration in mice. Behav Brain Res. 2013;244:107–15. https://doi.org/10.1016/j.bbr.2013.01.039.
Yang CH, Onda DA, Oakhill JS, Scott JW, Galic S, Loh K. Regulation of pancreatic β-cell function by the NPY system. Endocrinology (United States). 2021;162.https://doi.org/10.1210/endocr/bqab070.
Flood JF, Baker ML, Hernandez EN, Morley JE. Modulation of memory retention by neuropeptide K. Brain Res. 1990;520:284–90. https://doi.org/10.1016/0006-8993(90)91717-U.
Gutman AR, Yang Y, Ressler KJ, Davis M. The role of neuropeptide Y in the expression and extinction of fear-potentiated startle. J Neurosci. 2008;28:12682–90. https://doi.org/10.1523/JNEUROSCI.2305-08.2008.
Thorsell A, Svensson P, Wiklund L, Sommer W, Ekman R, Heilig M. Suppressed neuropeptide Y (NPY) mRNA in rat amygdala following restraint stress. Regul Pept. 1998;75–76:247–54. https://doi.org/10.1016/S0167-0115(98)00075-5.
Vocat C, Dunand M, Hubers SA, Bourdillon N, Millet GP, Brown NJ, et al. Quantification of neuropeptide Y and four of its metabolites in human plasma by micro-UHPLC-MS/MS. Anal Chem. 2020;92:859–66. https://doi.org/10.1021/acs.analchem.9b03505.
Jiménez-Lamana J, Marigliano L, Allouche J, Grassl B, Szpunar J, Reynaud S. A novel strategy for the detection and quantification of nanoplastics by single particle inductively coupled plasma mass spectrometry (ICP-MS). Anal Chem. 2020;92:11664–72. https://doi.org/10.1021/acs.analchem.0c01536.
Pu F, Elsen NL, Williams JD. Emerging chromatography-free high-throughput mass spectrometry technologies for generating hits and leads. ACS Med Chem Lett. 2020;11:2108–13. https://doi.org/10.1021/acsmedchemlett.0c00314.
Crespi F. Influence of neuropeptide Y and antidepressants upon cerebral monoamines involved in depression: an in vivo electrochemical study. Brain Res. 2011;1407:27–37. https://doi.org/10.1016/j.brainres.2011.05.033.
Liu FA, Ardabili N, Brown I, Rafi H, Cook C, Nikopoulou R, et al. Modified sawhorse waveform for the voltammetric detection of oxytocin. J Electrochem Soc. 2022;169:017512.https://doi.org/10.1149/1945-7111/ac4aae.
Jarosova R, Douglass AD, Johnson MA. Optimized sawhorse waveform for the measurement of oxytocin release in zebrafish. Anal Chem. 2022;94:2942–9. https://doi.org/10.1021/acs.analchem.1c04879.
Glover SD, Jorge C, Liang L, Valentine KG, Hammarström L, Tommos C. Photochemical tyrosine oxidation in the structurally well-defined α3Y protein: proton-coupled electron transfer and a long-lived tyrosine radical. J Am Chem Soc. 2014;136:14039–51. https://doi.org/10.1021/ja503348d.
Calhoun SE, Meunier CJ, Lee CA, McCarty GS, Sombers LA. Characterization of a multiple-scan-rate voltammetric waveform for real-time detection of met-enkephalin. ACS Chem Neurosci. 2019;10:2022–32. https://doi.org/10.1021/acschemneuro.8b00351.
Schmidt AC, Dunaway LE, Roberts JG, McCarty GS, Sombers LA. Multiple scan rate voltammetry for selective quantification of real-time enkephalin dynamics. Anal Chem. 2014;86:7806–12. https://doi.org/10.1021/ac501725u.
Vazquez Y, Cunci L, Fernandez-Vega L, Melendez-Rodriguez DE. Measurement of neuropeptide Y by square wave voltammetry using aptamer-modified platinum microelectrodes and methylene blue. ECS Meeting Abstracts; 2022/10//: The Electrochemical Society; 2022. p. 2455.
Seibold JM, Abeykoon SW, Ross AE, White RJ. Development of an electrochemical, aptamer-based sensor for dynamic detection of neuropeptide Y. ACS Sensors. 2023. https://doi.org/10.1021/acssensors.3c00855.
López L, Lozano K, Cruz J, Flores K, Fernández-Vega L, Cunci L. Measurement of neuropeptide Y with molecularly imprinted polypyrrole on carbon fiber microelectrodes. Neuropeptides. 2024;104.https://doi.org/10.1016/j.npep.2024.102413.
Rafi H, Zestos AG. Review—Recent advances in FSCV detection of neurochemicals via waveform and carbon microelectrode modification. J Electrochem Soc. 2021;168:057520-.https://doi.org/10.1149/1945-7111/ac0064.
Palanivel V, Gupta V, Mirshahvaladi SSO, Sharma S, Gupta V, Chitranshi N, et al. Neuroprotective effects of neuropeptide Y on human neuroblastoma SH-SY5Y cells in glutamate excitotoxicity and ER stress conditions. Cells. 2022;11.https://doi.org/10.3390/cells11223665.
Warren JJ, Tronic TA, Mayer JM. Thermochemistry of proton-coupled electron transfer reagents and its implications. Chem Rev. 2010;110:6961–7001. https://doi.org/10.1021/cr100085k.
Balasubramaniam A. Neuropeptide Y family of hormones: receptor subtypes and antagonists. Peptides. 1997;18:445–57. https://doi.org/10.1016/S0196-9781(96)00347-6.
Dumont Y, Quirion R. An overview of neuropeptide Y: pharmacology to molecular biology and receptor localization. 952006. pp. 7-33. https://doi.org/10.1007/3-7643-7417-9_2.
Cowley DJ, Hoflack JM, Pelton JT, Saudek V. Structure of neuropeptide Y dimer in solution. Eur J Biochem. 1992;205:1099–106. https://doi.org/10.1111/j.1432-1033.1992.tb16878.x.
Lagerström MC, Fredriksson R, Bjarnadóttir TK, Fridmanis D, Holmquist T, Andersson J, et al. Origin of the prolactin-releasing hormone (PRLH) receptors: evidence of coevolution between PRLH and a redundant neuropeptide Y receptor during vertebrate evolution. Genomics. 2005;85:688–703. https://doi.org/10.1016/j.ygeno.2005.02.007.
Chiku M, Horisawa K, Doi N, Yanagawa H, Einaga Y. Electrochemical detection of tyrosine derivatives and protein tyrosine kinase activity using boron-doped diamond electrodes. Biosens Bioelectron. 2010;26:235-40.https://doi.org/10.1016/j.bios.2010.06.027.
Bath BD, Martin HB, Wightman RM, Anderson MR. Dopamine adsorption at surface modified carbon-fiber electrodes. Langmuir. 2001;17:7032–9. https://doi.org/10.1021/la0106844.
Bath BD, Michael DJ, Trafton BJ, Joseph JD, Runnels PL, Wightman RM. Subsecond adsorption and desorption of dopamine at carbon-fiber microelectrodes. Anal Chem. 2000;72:5994–6002. https://doi.org/10.1021/ac000849y.
Takmakov P, Zachek MK, Keithley RB, Bucher ES, McCarty GS, Wightman RM. Characterization of local pH changes in brain using fast-scan cyclic voltammetry with carbon microelectrodes. Anal Chem. 2010;82:9892–900. https://doi.org/10.1021/ac102399n.
Heien MLAV, Phillips PEM, Stuber GD, Seipel AT, Wightman RM. Overoxidation of carbon-fiber microelectrodes enhances dopamine adsorption and increases sensitivity. Analyst. 2003;128:1413–9. https://doi.org/10.1039/b307024g.
Güell AG, Meadows KE, Unwin PR, MacPherson JV. Trace voltammetric detection of serotonin at carbon electrodes: comparison of glassy carbon, boron doped diamond and carbon nanotube network electrodes. Phys Chem Chem Phys. 2010;12:10108–14. https://doi.org/10.1039/c0cp00675k.
Patel AN, Tan SY, Miller TS, MacPherson JV, Unwin PR. Comparison and reappraisal of carbon electrodes for the voltammetric detection of dopamine. Anal Chem. 2013;85:11755–64. https://doi.org/10.1021/ac401969q.
Hao J, Xiao T, Wu F, Yu P, Mao L. High antifouling property of ion-selective membrane: toward in vivo monitoring of pH change in live brain of rats with membrane-coated carbon fiber electrodes. Anal Chem. 2016;88:11238–43. https://doi.org/10.1021/acs.analchem.6b03854.
Harreither W, Trouillon R, Poulin P, Neri W, Ewing AG, Safina G. Carbon nanotube fiber microelectrodes show a higher resistance to dopamine fouling. Anal Chem. 2013;85:7447–53. https://doi.org/10.1021/ac401399s.
Seaton BT, Hill DF, Cowen SL, Heien ML. Mitigating the effects of electrode biofouling-induced impedance for improved long-term electrochemical measurements in vivo. Anal Chem. 2020;92:6334–40. https://doi.org/10.1021/acs.analchem.9b05194.
Yang C, Wang Y, Jacobs CB, Ivanov IN, Venton BJ. O2 plasma etching and antistatic gun surface modifications for CNT yarn microelectrode improve sensitivity and antifouling properties. Anal Chem. 2017;89:5605–11. https://doi.org/10.1021/acs.analchem.7b00785.
Dunham KE, Venton BJ. Improving serotonin fast-scan cyclic voltammetry detection: new waveforms to reduce electrode fouling. Analyst. 2020;145:7437–46. https://doi.org/10.1039/d0an01406k.
Hashemi P, Dankoski EC, Petrovic J, Keithley RB, Wightman RM. Voltammetric detection of 5-hydroxytryptamine release in the rat brain. Anal Chem. 2009;81:9462–71. https://doi.org/10.1021/ac9018846.
Mendoza A, Asrat T, Liu F, Wonnenberg P, Zestos AG. Carbon nanotube yarn microelectrodes promote high temporal measurements of serotonin using fast scan cyclic voltammetry. Sensors (Switzerland). 2020;20.https://doi.org/10.3390/s20041173.
Zestos AG, Jacobs CB, Trikantzopoulos E, Ross AE, Venton BJ. Polyethylenimine carbon nanotube fiber electrodes for enhanced detection of neurotransmitters. Anal Chem. 2014;86:8568–75. https://doi.org/10.1021/ac5003273.
Takmakov P, Zachek MK, Keithley RB, Walsh PL, Donley C, McCarty GS, et al. Carbon microelectrodes with a renewable surface. Anal Chem. 2010;82:2020–8. https://doi.org/10.1021/ac902753x.
Raju D, Mendoza A, Wonnenberg P, Mohanaraj S, Sarbanes M, Truong C, et al. Polymer modified carbon fiber-microelectrodes and waveform modifications enhance neurotransmitter metabolite detection. Anal Methods. 2019;11:1620–30. https://doi.org/10.1039/c8ay02737d.
Lee HS, Kim SM, Jang JH, Park HD, Lee SY. Serum 5-hydroxyindoleacetic acid and ratio of 5-hydroxyindoleacetic acid to serotonin as metabolomics indicators for acute oxidative stress and inflammation in vancomycin-associated acute kidney injury. Antioxidants. 2021;10.https://doi.org/10.3390/antiox10060895.
Beal MF, Frank RC, Ellison DW, Martin JB. The effect of neuropeptide Y on striatal catecholamines. Neurosci Lett. 1986;71:123.https://doi.org/10.1016/0304-3940(86)90267-3.
Myers RD, Lankford MF, Roscoe AK. Neuropeptide Y perfused in the preoptic area of Shi ts extracellular efflux of dopamine, norepiaepbrm serotonin during hypothermia and feeding. Neurochem Res. 1996;21:637–48. https://doi.org/10.1007/BF02527719.
Ramos EJB, Meguid MM, Campos ACL, Coelho JCU. Neuropeptide Y, α-melanocyte-stimulating hormone, and monoamines in food intake regulation. Nutrition. 2005;21:269–79. https://doi.org/10.1016/j.nut.2004.06.021.
Zoubek J, Somogyi GT, De Groat WC. A comparison of inhibitory effects of neuropeptide Y on rat urinary bladder, urethra, and vas deferens. Am J Physiol. 1993;265:R537-43. https://doi.org/10.1152/ajpregu.1993.265.3.R537.
Ezzat1 H, Abdel S, Saeed1 W, Abouelsaad2 A, Teama NM. Assessment of the association between neuropeptide Y and chronic kidney disease progression. Egypt J Hosp Med. 2020;80.https://doi.org/10.21608/EJHM.2020.105926.
Satoh C, Satoh F, Takahashi K. Elevated plasma immunoreactive concentrations and its increased patients with advanced diabetic neuropeptide Y urinary excretion in nephropathy. Endocr J. 1999;46:139–46. https://doi.org/10.1507/endocrj.46.139.
Lay AC, Barrington AF, Hurcombe JA, Ramnath RD, Graham M, Lewis PA, et al. A role for NPY-NPY2R signaling in albuminuric kidney disease. Proc Natl Acad Sci U S A. 2020;117:15862–73. https://doi.org/10.1073/pnas.2004651117.
Zestos A, Alyamni N, Abdullaeva C. Chemical analysis of neuropeptide Y and glutamate using carbon fiber microelectrodes and fast-scan cyclic voltammetry. ASPET; 2024.
Funding
The authors would like to acknowledge the following funding sources: NASA DC Space Grant, American University Faculty Mellon, NIH 1R41NS113702-01 (AGZ), Pittcon SACP Starter Grant, ACS PRF, DC-CFAR, and NSF I-Corps #1936173 (AGZ).
Author information
Authors and Affiliations
Contributions
NA performed the experiments, analyzed the data, and wrote the manuscript. JLA assisted in editing and writing the manuscript. AGZ assisted in conceptualization, project supervision, analyzing the data, and writing and editing the manuscript.
Corresponding author
Ethics declarations
Ethics approval
This study was approved to use artificial urine samples for research purposes.
Source of biological material
Carolina Biological Supply
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Published in the topical collection Emerging Trends in Electrochemical Analysis with guest editors Sabine Szunerits, Wei Wang, and Adam T. Woolley.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Alyamni, N., Abot, J.L. & Zestos, A.G. Voltammetric detection of Neuropeptide Y using a modified sawhorse waveform. Anal Bioanal Chem 416, 4807–4818 (2024). https://doi.org/10.1007/s00216-024-05373-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-024-05373-y